APA on Sleep Quality in Women With PCOS
- Conditions
- Polycystic Ovary Syndrome
- Interventions
- Other: Auricular point acupressure (APA)
- Registration Number
- NCT06009172
- Brief Summary
Women with polycystic ovary syndrome (PCOS) appear to have an increased frequency of sleep problems. The aim of this study was to explore the effect of auricular point acupressure (APA) pressure on sleep quality in women with PCOS.
- Detailed Description
Polycystic ovary syndrome (PCOS) is a prevalent disorder affecting 5-18% of reproductive-age women. In recent years, women with PCOS appear to have an increased frequency of sleep problems, and the prevalence of poor sleep in PCOS is high at 31%. The aim of this study was to explore the effect of auricular point acupressure (APA) pressure on sleep quality in women with PCOS. We verified the effect of APA pressure on sleep quality, quality of life, anxiety level, sex hormone indexes, and biochemical indexes in two groups after the intervention. So as to provide a sleep management strategy in PCOS women for future clinical practice guidelines.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 88
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description APA group Auricular point acupressure (APA) -
- Primary Outcome Measures
Name Time Method Pittsburgh Sleep Quality Index (PSQI) Baseline and 30 days The PSQI is a cornerstone tool for the assessment of sleep quality
- Secondary Outcome Measures
Name Time Method fasting serum insulin (pmol/L) Baseline and 30 days fasting blood-glucose(mmol/L) Baseline and 30 days Modified Polycystic Ovary Syndrome Health Related Quality of Life Questionnaire (MPCOSQ) Baseline and 30 days Self-Rating Anxiety Scale (SAS) Baseline and 30 days The cutoff value for anxiety assessment of Self-Rating Anxiety Scale (SAS) is 50 oints, and the higher the score, the more obvious the anxiety tendency. Below 49 is normal; 50-59 is mild; 60-69 is moderate; A score of 69 or above is considered severe.
Testosterone (T) level(ng/mL) Baseline and 30 days Progesterone (P) level(ng/mL) Baseline and 30 days
Trial Locations
- Locations (1)
Department of Endocrinology and Diabetes, the First Affiliated Hospital of Xiamen University, School of medicine, Xiamen university, Xiamen, China
🇨🇳Xiamen, Fujian, China